West Pharmaceutical stock price target raised to $370 by BofA on growth outlook
PositiveFinancial Markets

West Pharmaceutical's stock price target has been raised to $370 by Bank of America, reflecting a strong growth outlook for the company. This adjustment indicates confidence in West's future performance and could attract more investors, highlighting the company's potential in the pharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System










